Related Experiment Videos
Specific DNA binding by different classes of human p53 mutants
Abstract:
The p53 protein is a multifunctional transcription factor which orchestrates cellular responses to DNA damage, so helping to conserve genomic stability. It may also regulate genes involved in intercellular signalling, such as thrombospondin, a negative regulator of angiogenesis and metastatic spread. Activation of p53 target genes requires sequence-specific DNA binding, a function which maps to the central core of the protein. Missense point mutations within this domain inactivate p53 tumour suppressor function and involve either (i) DNA contact residues, or (ii) residues important for conformational structure. Using in vitro techniques we have analysed seven DNA contact mutants and 17 structural mutants known to occur in cancer. We show that DNA contact mutants can be carried into specific DNA interaction when co-expressed with wild type protein. For structural mutants, 9/17 retained DNA binding capacity and, with one exception, DNA binding correlated with conformational flexibility of the mutant protein. The exception was Asp281, which appeared essential for DNA interaction, probably due to its ability to form salt bridges with DNA contact residues Arg273 and Arg280. We suggest that different classes of p53 mutant may prove amenable to different strategies for restoration of wild type tumour suppressor function as means of anti-cancer therapy.
Insights
Restoring tumor suppressor function of p53 protein, crucial for DNA repair and genomic stability, may be possible through targeted therapies. Different p53 mutant classes show varying DNA binding capacities, suggesting distinct therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 protein is a key transcription factor regulating cellular responses to DNA damage and maintaining genomic stability.
- p53 also influences intercellular signaling pathways, including angiogenesis and metastasis, via genes like thrombospondin.
- Sequence-specific DNA binding in the central core domain is essential for p53's transcriptional activity.
Purpose of the Study:
- To investigate the DNA binding capabilities of different classes of p53 mutants found in cancer.
- To explore the relationship between mutant p53 structure, DNA binding, and conformational flexibility.
- To assess the potential for restoring wild-type p53 tumor suppressor function through targeted therapeutic strategies.
Main Methods:
- In vitro analysis of seven DNA contact mutants and 17 structural mutants of p53.
- Co-expression of DNA contact mutants with wild-type p53 to assess DNA interaction.
- Evaluation of DNA binding capacity and conformational flexibility in structural mutants.
Main Results:
- DNA contact mutants can regain specific DNA interaction when co-expressed with wild-type p53.
- Nine out of 17 structural mutants retained DNA binding capacity.
- For most structural mutants, DNA binding correlated with conformational flexibility, with Asp281 being a notable exception essential for DNA interaction.
Conclusions:
- Different classes of p53 mutants exhibit distinct properties regarding DNA binding and flexibility.
- The findings suggest that specific therapeutic strategies may be developed to restore wild-type p53 tumor suppressor function in cancer.
- Understanding mutant p53 behavior is crucial for developing novel anti-cancer therapies targeting p53 restoration.